Differential protein-protein interactions of full length human FasL and FasL fragments generated by proteolysis

Experimental Cell Research

Volumn 320, Issue 2, 2014, Pages 290-301

  Lettau, Marcus ^a   Voss, Matthias ^a,b   Ebsen, Henriette ^a   Kabelitz, Dieter ^a   Janssen, Ottmar ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

FasL; Intramembrane proteolysis; Monoclonal antibody; PCH proteins; Protein protein interaction; Proteolysis; Signal transduction; Sorting nexins; T lymphocytes

Indexed keywords

FAS LIGAND; MONOCLONAL ANTIBODY; PROTEIN SH3; SORTING NEXIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; IMMUNOPRECIPITATION; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING;

(F-)BAR; (FER/CIP4 HOMOLOGY-)BIN-AMPHIPHYSIN-RVS; A DISINTEGRIN AND METALLOPROTEINASE; ADAM; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; ESCRT; FAS LIGAND; FASL; I-CLIP; ICD; INTRACELLULAR DOMAIN; INTRAMEMBRANE PROTEOLYSIS; INTRAMEMBRANE-CLEAVING PROTEASE; MAB; MONOCLONAL ANTIBODY; N-TERMINAL FRAGMENT; NTF; PCH; PCH PROTEINS; POMBE CDC15 HOMOLOGY; PRD; PROLINE-RICH DOMAIN; PROTEIN-PROTEIN INTERACTION; PROTEOLYSIS; REGULATED INTRAMEMBRANE PROTEOLYSIS; RIP; SH3; SIGNAL PEPTIDE PEPTIDASE LIKE 2A; SIGNAL TRANSDUCTION; SNX; SORTING NEXIN; SORTING NEXINS; SPPL2A; SRC HOMOLOGY 3; T LYMPHOCYTES; TNF; TUMOR NECROSIS FACTOR;

ANIMALS; CELLS, CULTURED; FAS LIGAND PROTEIN; HEK293 CELLS; HUMANS; JURKAT CELLS; K562 CELLS; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEOLYSIS; SUBSTRATE SPECIFICITY;

EID: 84890859528     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.11.016     Document Type: Article

References (61)

1. Nagata S. Fas ligand-induced apoptosis. Annu. Rev. Genet. 1999, 33:29-55.
2. Janssen O., Stocker A., Sanzenbacher R., Oberg H.H., Siddiqi M.A., Kabelitz D. Differential regulation of activation-induced cell death in individual human T cell clones. Int. Arch. Allergy Immunol. 2000, 121:183-193.
3. Janssen O., Qian J., Linkermann A., Kabelitz D. CD95 ligand - death factor and costimulatory molecule?. Cell Death Differ. 2003, 10:1215-1225.
4. Lettau M., Paulsen M., Kabelitz D., Janssen O. Storage, expression and function of Fas ligand, the key death factor of immune cells. Curr. Med. Chem. 2008, 15:1684-1696.
5. Trambas C.M., Griffiths G.M. Delivering the kiss of death. Nat. Immunol. 2003, 4:399-403.
6. Krammer P.H. CD95's deadly mission in the immune system. Nature 2000, 407:789-795.
7. Green D.R., Droin N., Pinkoski M. Activation-induced cell death in T cells. Immunol. Rev. 2003, 193:70-81.
8. Sun M., Lee S., Karray S., Levi-Strauss M., Ames K.T., Fink P.J. Cutting edge: two distinct motifs within the Fas ligand tail regulate Fas ligand-mediated costimulation. J. Immunol. 2007, 179:5639-5643.
9. Voss M., Lettau M., Paulsen M., Janssen O. Posttranslational regulation of Fas ligand function. Cell Commun. Signal 2008, 6:11.
10. Paulsen M., Mathew B., Qian J., Lettau M., Kabelitz D., Janssen O. FasL cross-linking inhibits activation of human peripheral T cells. Int. Immunol. 2009, 21:587-598.
11. Paulsen M., Janssen O. Pro- and anti-apoptotic CD95 signaling in T cells. Cell Commun. Signal 2011, 9:7.
12. Lettau M., Paulsen M., Schmidt H., Janssen O. Insights into the molecular regulation of FasL (CD178) biology. Eur. J. Cell Biol. 2011, 90:456-466.
13. Paulsen M., Valentin S., Mathew B., Adam-Klages S., Bertsch U., Lavrik I., Krammer P.H., Kabelitz D., Janssen O. Modulation of CD4+ T-cell activation by CD95 co-stimulation. Cell Death Differ. 2011, 18:619-631.
14. Hane M., Lowin B., Peitsch M., Becker K., Tschopp J. Interaction of peptides derived from the Fas ligand with the Fyn-SH3 domain. FEBS Lett. 1995, 373:265-268.
15. Wenzel J., Sanzenbacher R., Ghadimi M., Lewitzky M., Zhou Q., Kaplan D.R., Kabelitz D., Feller S.M., Janssen O. Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor. FEBS Lett. 2001, 509:255-262.
16. Ghadimi M.P., Sanzenbacher R., Thiede B., Wenzel J., Qian J., Plomann M., Borkhardt A., Kabelitz D., Janssen O. Identification of interaction partners of the cytosolic polyproline region of CD95 ligand (CD178). FEBS Lett. 2002, 519:50-58.
17. Baum W., Kirkin V., Fernandez S.B., Pick R., Lettau M., Janssen O., Zörnig M. Binding of the intracellular Fas ligand (FasL) domain to the adapter protein PSTPIP results in a cytoplasmic localization of FasL. J. Biol. Chem. 2005, 280:40012-40024.
18. Qian J., Chen W., Lettau M., Podda G., Zörnig M., Kabelitz D., Janssen O. Regulation of FasL expression: a SH3 domain containing protein family involved in the lysosomal association of FasL. Cell Signal 2006, 18:1327-1337.
19. Thornhill P.B., Cohn J.B., Drury G., Stanford W.L., Bernstein A., Desbarats J. A proteomic screen reveals novel Fas ligand interacting proteins within nervous system Schwann cells. FEBS Lett. 2007, 581:4455-4462.
20. Voss M., Lettau M., Janssen O. Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening. BMC Immunol. 2009, 10:53.
21. Lettau M., Paulsen M., Kabelitz D., Janssen O. FasL expression and reverse signalling. Results Probl. Cell Differ. 2009, 49:49-61.
22. Sun M., Ames K.T., Suzuki I., Fink P.J. The cytoplasmic domain of Fas ligand costimulates TCR signals. J. Immunol. 2006, 177:1481-1491.
23. Zuccato E., Blott E.J., Holt O., Sigismund S., Shaw M., Bossi G., Griffiths G.M. Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation. J. Cell Sci. 2007, 120:191-199.
24. Blott E.J., Bossi G., Clark R., Zvelebil M., Griffiths G.M. Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail. J. Cell Sci. 2001, 114:2405-2416.
25. Blott E.J., Griffiths G.M. Secretory lysosomes. Nat. Rev. Mol. Cell Biol. 2002, 3:122-131.
26. Bossi G., Griffiths G.M. CTL secretory lysosomes: biogenesis and secretion of a harmful organelle. Semin. Immunol. 2005, 17:87-94.
27. Lettau M., Schmidt H., Kabelitz D., Janssen O. Secretory lysosomes and their cargo in T and NK cells. Immunol. Lett. 2007, 108:10-19.
28. Schmidt H., Gelhaus C., Nebendahl M., Lettau M., Lucius R., Leippe M., Kabelitz D., Janssen O. Effector granules in human T lymphocytes: the luminal proteome of secretory lysosomes from human T cells. Cell Commun. Signal 2011, 9:4.
29. Schmidt H., Gelhaus C., Nebendahl M., Lettau M., Lucius R., Leippe M., Kabelitz D., Janssen O. Effector granules in human T lymphocytes: proteomic evidence for two distinct species of cytotoxic effector vesicles. J. Proteome Res. 2011, 10:1603-1620.
30. Aspenström P., Fransson A., Richnau N. Pombe Cdc15 homology proteins: regulators of membrane dynamics and the actin cytoskeleton. Trends Biochem. Sci. 2006, 31:670-679.
31. Aspenström P. Roles of F-BAR/PCH proteins in the regulation of membrane dynamics and actin reorganization. Int. Rev. Cell Mol. Biol. 2009, 272:1-31.
32. Chitu V., Stanley E.R. Pombe Cdc15 homology (PCH) proteins: coordinators of membrane-cytoskeletal interactions. Trends Cell Biol. 2007, 17:145-156.
33. Linkermann A., Qian J., Lettau M., Kabelitz D., Janssen O. Considering Fas ligand as a target for therapy. Expert Opin. Ther. Targets 2005, 9:119-134.
34. Tanaka M., Itai T., Adachi M., Nagata S. Downregulation of Fas ligand by shedding. Nat. Med. 1998, 4:31-36.
35. Schneider P., Holler N., Bodmer J.L., Hahne M., Frei K., Fontana A., Tschopp J. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 1998, 187:1205-1213.
36. Strasser A., Jost P.J., Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity 2009, 30:180-192.
37. O' Reilly L.A., Tai L., Lee L., Kruse E.A., Grabow S., Fairlie W.D., Haynes N.M., Tarlinton D.M., Zhang J.G., Belz G.T., Smyth M.J., Bouillet P., Robb L., Strasser A. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature 2009, 461:659-663.
38. Schulte M., Reiss K., Lettau M., Maretzky T., Ludwig A., Hartmann D., de Strooper B., Janssen O., Saftig P. ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ. 2007, 14:1040-1049.
39. Kirkin V., Cahuzac N., Guardiola-Serrano F., Huault S., Lückerath K., Friedmann E., Novac N., Wels W.S., Martoglio B., Hueber A.O., Zörnig M. The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells. Cell Death Differ. 2007, 14:1678-1687.
40. Mumm J.S., Kopan R. Notch signaling: from the outside. Dev. Biol. 2000, 228:151-165.
41. Fluhrer R., Grammer G., Israel L., Condron M.M., Haffner C., Friedmann E., Bohland C., Imhof A., Martoglio B., Teplow D.B., Haass C. A gamma-secretase-like intramembrane cleavage of TNFalpha by the GxGD aspartyl protease SPPL2b. Nat. Cell Biol. 2006, 8:894-896.
42. Friedmann E., Hauben E., Maylandt K., Schleeger S., Vreugde S., Lichtenthaler S.F., Kuhn P.H., Stauffer D., Rovelli G., Martoglio B. SPPL2a and SPPL2b promote intramembrane proteolysis of TNFalpha in activated dendritic cells to trigger IL-12 production. Nat. Cell Biol. 2006, 8:843-848.
43. Lettau M., Gerneth A., Janssen O. Novel monoclonal antibodies for the investigation of PCH family proteins. Signal Transduct. 2007, 7:320-328.
44. Lettau M., Qian J., Linkermann A., Latreille M., Larose L., Kabelitz D., Janssen O. The adapter protein Nck interacts with Fas ligand: guiding the death factor to the cytotoxic immunological synapse. Proc. Natl. Acad. Sci. USA 2006, 103:5911-5916.
45. Smith D., Sieg S., Kaplan D. Technical note: aberrant detection of cell surface Fas ligand with anti-peptide antibodies. J. Immunol. 1998, 160:4159-4160.
46. Ebsen H., Schröder A., Kabelitz D., Janssen O. Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells. PLoS One 2013, 8:e76853.
47. Lettau M., Qian J., Kabelitz D., Janssen O. Activation-dependent FasL expression in T lymphocytes and natural killer cells. Signal Transduct. 2004, 4:206-211.
48. Bossi G., Griffiths G.M. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med. 1999, 5:90-96.
49. Linkermann A., Gelhaus C., Lettau M., Qian J., Kabelitz D., Janssen O. Identification of interaction partners for individual SH3 domains of Fas ligand associated members of the PCH protein family in T lymphocytes. Biochim.Biophys.Acta 2009, 1794:168-176.
50. Carlton J.G., Bujny M.V., Peter B.J., Oorschot V.M., Rutherford A., Arkell R.S., Klumperman J., McMahon H.T., Cullen P.J. Sorting nexin-2 is associated with tubular elements of the early endosome, but is not essential for retromer-mediated endosome-to-TGN transport. J. Cell Sci. 2005, 118:4527-4539.
51. Cullen P.J. Endosomal sorting and signalling: an emerging role for sorting nexins. Nat. Rev. Mol. Cell Biol. 2008, 9:574-582.
52. Haberg K., Lundmark R., Carlsson S.R. SNX18 is an SNX9 paralog that acts as a membrane tubulator in AP-1-positive endosomal trafficking. J. Cell Sci. 2008, 121:1495-1505.
53. Lückerath K., Kirkin V., Melzer I.M., Thalheimer F.B., Siele D., Milani W., Adler T., Aguilar-Pimentel A., Horsch M., Michel G., Beckers J., Busch D.H., Ollert M., Gailus-Durner V., Fuchs H., Hrabe de A.M., Staal F.J., Rajalingam K., Hueber A.O., Strobl L.J., Zimber-Strobl U., Zörnig M. Immune modulation by Fas ligand reverse signaling: lymphocyte proliferation is attenuated by the intracellular Fas ligand domain. Blood 2011, 117:519-529.
54. Steiner H., Fluhrer R., Haass C. Intramembrane proteolysis by gamma-secretase. J. Biol. Chem. 2008, 283:29627-29631.
55. Voss M., Schröder B., Fluhrer R. Mechanism, specificity, and physiology of signal peptide peptidase (SPP) and SPP-like proteases. Biochim. Biophys. Acta 1828, 2013:2828-2839.
56. Cullen P.J. Phosphoinositides and the regulation of tubular-based endosomal sorting. Biochem. Soc. Trans. 2011, 39:839-850.
57. Cullen P.J., Korswagen H.C. Sorting nexins provide diversity for retromer-dependent trafficking events. Nat. Cell Biol. 2012, 14:29-37.
58. Lundmark R., Carlsson S.R. SNX9 - a prelude to vesicle release. J. Cell Sci. 2009, 122:5-11.
59. Zhang J., Zhang X., Guo Y., Xu L., Pei D. Sorting nexin 33 induces mammalian cell micronucleated phenotype and actin polymerization by interacting with Wiskott-Aldrich syndrome protein. J. Biol. Chem. 2009, 284:21659-21669.
60. Ma M.P., Chircop M. SNX9, SNX18 and SNX33 are required for progression through and completion of mitosis. J. Cell Sci. 2012, 125:4372-4382.
61. Feng Y., Hartig S.M., Bechill J.E., Blanchard E.G., Caudell E., Corey S.J. The Cdc42-interacting protein-4 (CIP4) gene knock-out mouse reveals delayed and decreased endocytosis. J. Biol. Chem. 2010, 285:4348-4354.